Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 160491, 6 pages
http://dx.doi.org/10.1155/2013/160491
Review Article

The Immune Factors Involved in the Pathogenesis, Diagnosis, and Treatment of Sjogren's Syndrome

State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China

Received 3 May 2013; Accepted 20 June 2013

Academic Editor: Guixiu Shi

Copyright © 2013 Yi-fan Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. F. Tabbara and C. L. Vera-Cristo, “Sjogren syndrome,” Current Opinion in Ophthalmology, vol. 11, no. 6, pp. 449–454, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Vasudevan and P. G. Bhide, “Angiogenesis in the embryonic CNS: a new twist on an old tale,” Cell Adhesion & Migration, vol. 2, no. 3, pp. 167–169, 2008. View at Google Scholar · View at Scopus
  3. A. G. Tzioufas, I. P. Tatouli, and H. M. Moutsopoulos, “Autoantibodies in Sjögren's syndrome: clinical presentation and regulatory mechanisms,” La Presse Médicale, vol. 41, no. 9, part 2, pp. e451–e460, 2012. View at Publisher · View at Google Scholar
  4. J. G. Routsias and A. G. Tzioufas, “Sjögren's syndrome—study of autoantigens and autoantibodies,” Clinical Reviews in Allergy and Immunology, vol. 32, no. 3, pp. 238–251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. B. Elkon, A. E. Gharavi, G. R. V. Hughes, and H. M. Moutsoupoulos, “Autoantibodies in the sicca syndrome,” Annals of the Rheumatic Diseases, vol. 43, no. 2, pp. 243–245, 1984. View at Google Scholar · View at Scopus
  6. P. Tengner, A.-K. Halse, H.-J. Haga, R. Jonsson, and M. Wahren-Herlenius, “Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cels in salivary glands from patients with Sjögren’s syndrome,” Arthritis & Rheumatism, vol. 41, no. 12, pp. 2238–2248, 1998. View at Google Scholar
  7. A. R. Hammi, I. H. Al-Hashimi, M. E. Nunn, and M. Zipp, “Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren’s syndrome,” Journal of Oral Pathology & Medicine, vol. 34, no. 4, pp. 198–203, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. B. K. S. Davidson, C. A. Kelly, and I. D. Griffiths, “Primary Sjögren’s syndrome in the North East of England: a long-term follow-up study,” Rheumatology, vol. 38, no. 3, pp. 245–253, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. A. L. Fauchais, C. Martel, G. Gondran et al., “Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease,” Autoimmunity Reviews, vol. 9, no. 9, pp. 595–599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Selmi, P. Luigi Meroni, and M. Eric Gershwin, “Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis,” Journal of Autoimmunity, vol. 39, no. 1-2, pp. 34–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Passafaro, S. Reina, L. Sterin-Borda, and E. Borda, “Cholinergic autoantibodies from primary Sjögren's syndrome modulate submandibular gland Na+/K+-ATPase activity via prostaglandin E2and cyclic AMP,” European Journal of Oral Sciences, vol. 118, no. 2, pp. 131–138, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. M. Smith and L. J. Dawson, “Autoantibodies and Sjögren’s syndrome: a physiologist's perspective,” Current Pharmaceutical Biotechnology, vol. 13, no. 10, pp. 2063–2070, 2012. View at Publisher · View at Google Scholar
  13. H. Tsuboi, Y. Nakamura, M. Iizuka, N. Matsuo, I. Matsumoto, and T. Sumida, “Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor,” Modern Rheumatology, vol. 22, no. 2, pp. 264–271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Singh and P. L. Cohen, “The T cell in Sjögren’s syndrome: force majeure, not spectateur,” Journal of Autoimmunity, vol. 39, no. 3, pp. 229–233, 2012. View at Publisher · View at Google Scholar
  15. I. J. Crane and J. V. Forrester, “Th1 and Th2 lymphocytes in autoimmune disease,” Critical Reviews in Immunology, vol. 25, no. 2, pp. 75–102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. R. I. Fox and H.-I. Kang, “Pathogenesis of Sjögren’s syndrome,” Rheumatic Disease Clinics of North America, vol. 18, no. 3, pp. 517–538, 1992. View at Google Scholar · View at Scopus
  17. R. Bertorello, M. P. Cordone, P. Contini et al., “Increased levels of interleukin-10 in saliva of Sjögren’s syndrome patients. Correlation with disease activity,” Clinical and Experimental Medicine, vol. 4, no. 3, pp. 148–151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. D. I. Mitsias, A. G. Tzioufas, C. Veiopoulou et al., “The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren’s syndrome,” Clinical & Experimental Immunology, vol. 128, no. 3, pp. 562–568, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Sakai, Y. Sugawara, T. Kuroishi, T. Sasano, and S. Sugawara, “Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren’s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18,” The Journal of Immunology, vol. 181, no. 4, pp. 2898–2906, 2008. View at Google Scholar · View at Scopus
  20. C. Q. Nguyen, M. H. Hu, Y. Li, C. Stewart, and A. B. Peck, “Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice,” Arthritis & Rheumatism, vol. 58, no. 3, pp. 734–743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Cornec, V. Devauchelle-Pensec, G. J. Tobon, J. O. Pers, S. Jousse-Joulin, and A. Saraux, “B cells in Sjögren’s syndrome: from pathophysiology to diagnosis and treatment,” Journal of Autoimmunity, vol. 39, no. 3, pp. 161–167, 2012. View at Publisher · View at Google Scholar
  22. H. M. Guay, J. Larkin III, C. C. Picca, L. Panarey, and A. J. Caton, “Spontaneous autoreactive memory B cell formation driven by a high frequency of autoreactive CD4+ T cells,” The Journal of Immunology, vol. 178, no. 8, pp. 4793–4802, 2007. View at Google Scholar · View at Scopus
  23. A. Hansen, C. Daridon, and T. Dörner, “What do we know about memory B cells in primary Sjögren's syndrome?” Autoimmunity Reviews, vol. 9, no. 9, pp. 600–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. A. Aqrawi, K. Skarstein, G. Bredholt, J. G. Brun, and K. A. Brokstad, “Autoantigen-specific memory B cells in primary Sjögren's syndrome,” Scandinavian Journal of Immunology, vol. 75, no. 1, pp. 61–68, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Pascual, Y. J. Liu, A. Magalski, O. de Bouteiller, J. Banchereau, and J. D. Capra, “Analysis of somatic mutation in five B cell subsets of human tonsil,” Journal of Experimental Medicine, vol. 180, no. 1, pp. 329–339, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. Varin, T. Guerrier, V. Devauchelle-Pensec, C. Jamin, P. Youinou, and J. O. Pers, “In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation,” Autoimmunity Reviews, vol. 11, no. 4, pp. 252–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Daridon, V. Devauchelle, P. Hutin et al., “Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren’s syndrome,” Arthritis & Rheumatism, vol. 56, no. 4, pp. 1134–1144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Groom, S. L. Kalled, A. H. Cutler et al., “Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome,” The Journal of Clinical Investigation, vol. 109, no. 1, pp. 59–68, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. W. H. Abdulahad, F. G. M. Kroese, A. Vissink, and H. Bootsma, “Immune regulation and B-cell depletion therapy in patients with primary Sjögren’s syndrome,” Journal of Autoimmunity, vol. 39, no. 1-2, pp. 103–111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. M. Meijer, P. M. Meiners, A. Vissink et al., “Effectiveness of rituximab treatment in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled trial,” Arthritis & Rheumatism, vol. 62, no. 4, pp. 960–968, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. P. M. Meiners, A. Vissink, C. G. Kallenberg, F. G. Kroese, and H. Bootsma, “Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?” Expert Opinion on Biological Therapy, vol. 11, no. 10, pp. 1381–1394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. O. Pers, V. Devauchelle, C. Daridon et al., “BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren’s syndrome,” Arthritis & Rheumatism, vol. 56, no. 5, pp. 1464–1477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. B. Harley, R. H. Scofield, and M. Reichlin, “Anti-Ro in Sjögren’s syndrome and systemic lupus erythematosus,” Rheumatic Disease Clinics of North America, vol. 18, no. 2, pp. 337–358, 1992. View at Google Scholar · View at Scopus
  34. A. G. Tzioufas, E. K. Kapsogeorgou, and H. M. Moutsopoulos, “Pathogenesis of Sjögren's syndrome: what we know and what we should learn,” Journal of Autoimmunity, vol. 39, no. 1-2, pp. 4–8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. G. Tzioufas, R. Wassmuth, U. G. Dafni et al., “Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study,” Annals of the Rheumatic Diseases, vol. 61, no. 5, pp. 398–404, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Lisi, M. Sisto, D. D. Lofrumento et al., “Altered IκBα expression promotes NF-κB activation in monocytes from primary Sjögren's syndrome patients,” Pathology, vol. 44, no. 6, pp. 557–561, 2012. View at Google Scholar
  37. H. F. Cay, I. Sezer, S. Dogan et al., “Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren’s syndrome,” Clinical and Experimental Rheumatology, vol. 30, no. 6, pp. 843–849, 2012. View at Google Scholar